Nicola Isabella, Gallina Giovanni, Cagnotti Giulia, Gianella Paola, Valentini Flaminia, D'Angelo Antonio, Bellino Claudio
Department of Clinical Science, Faculty of Veterinary Medicine, Université de Montréal, 3200 Rue Sicotte, St-Hyacinthe, QC J2S 7C6, Canada.
Department of Veterinary Sciences, Clinical Section, University of Turin, Largo Paolo Braccini 2, 10095 Grugliasco, TO, Italy.
Animals (Basel). 2021 Jun 28;11(7):1925. doi: 10.3390/ani11071925.
The abuse or misuse of antimicrobials in animal production is thought to be a potential factor in the development of antimicrobial resistance in veterinary and human medicine. With this study, we wanted to quantify antimicrobial usage in beef fattening operations in northwestern Italy and to identify factors potentially influencing antimicrobial usage. The sample was composed of 26 beef fattening operations that import heifers and bulls from France. Data were extracted from the 2014 and 2015 treatment registers kept by the farmers. The mean (±SD) number of animal daily doses per animal (nADDa) per year for each farm was 3 (±2.1) during the study period (2014-2015). Group antimicrobial treatments (57.5% of all treatments) were often administered orally (70.5%) and consisted overwhelmingly of doxycycline (97%). Individual treatments (42.5% of all treatments) were administered parenterally (98.1%) and the most often used active substances were florfenicol (19.9%), marbofloxacin (19.5%), and tylosin (12.4%). There was a negative correlation between the nADDa for total and group treatments and average batch weight at arrival and between the amount of straw added per animal per day and the nADDa ( ≤ 0.05). Our data show that antimicrobials critical for human medicine were often used in beef fattening operations in northwestern Italy before the European guidelines for the prudent use of antimicrobials in veterinary medicine were issued. Additionally, the use of antimicrobials as a preventive group treatment was still widespread, mostly in lighter weight animals.
动物生产中抗菌药物的滥用或误用被认为是兽医学和人类医学中产生抗菌药物耐药性的一个潜在因素。通过这项研究,我们想要量化意大利西北部肉牛育肥场的抗菌药物使用情况,并确定可能影响抗菌药物使用的因素。样本由26个从法国进口小母牛和公牛的肉牛育肥场组成。数据从农民保存的2014年和2015年治疗记录中提取。在研究期间(2014 - 2015年),每个农场每年每头动物的平均(±标准差)动物每日剂量数(nADDa)为3(±2.1)。群体抗菌治疗(占所有治疗的57.5%)通常口服给药(70.5%),绝大多数由强力霉素组成(97%)。个体治疗(占所有治疗的42.5%)通过胃肠外给药(98.1%),最常用的活性物质是氟苯尼考(19.9%)、马波沙星(19.5%)和泰乐菌素(12.4%)。总治疗和群体治疗的nADDa与到达时的平均批次重量之间,以及每头动物每天添加的稻草量与nADDa之间存在负相关(≤0.05)。我们的数据表明,在欧洲兽用抗菌药物谨慎使用指南发布之前,对人类医学至关重要的抗菌药物在意大利西北部的肉牛育肥场中经常被使用。此外,作为预防性群体治疗使用抗菌药物仍然很普遍,主要用于体重较轻的动物。